$MDNAF #OTCQB Medicenna Therapeutics Corp. (MDNAF: OTCQB) | Medicenna Presents Preliminary Top-Line Clinical Results from their Phase 2b Trial of MDNA55 in Recurrent Glioblastoma

OTC Markets | MDNAF

Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities.

Copyright 2019 – OTC Markets Group Inc.

News Link